Dae W. Kim

Gangneung, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 245 publications

RETRACTED: Choi et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease. Molecules 2021, 26, 3329.

RETRACTED: Choi et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease. Molecules 2021, 26, 3329.

Journal: Molecules (Basel, Switzerland)
Published: July 07, 2026

Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration.

Chronic periodontitis and systemic inflammation in the elderly: implications for neurodegeneration.

Journal: Journal of neuroinflammation
Published: September 15, 2025

Pathophysiological Divergence Between Vascular and Post-Stroke Dementia: Bridging Human and Experimental Perspectives.

Pathophysiological Divergence Between Vascular and Post-Stroke Dementia: Bridging Human and Experimental Perspectives.

Journal: Journal of integrative neuroscience
Published: August 05, 2025

Neuroprotective Effects of PEP-1-PGAM5 via the Attenuation of Oxidative Stress and Apoptosis in Parkinson's Disease.

Neuroprotective Effects of PEP-1-PGAM5 via the Attenuation of Oxidative Stress and Apoptosis in Parkinson's Disease.

Journal: Journal of neurochemistry
Published: July 01, 2025

Therapeutic potential of porphyran in mitigating ischemia-reperfusion injury in gerbil hippocampus.

Therapeutic potential of porphyran in mitigating ischemia-reperfusion injury in gerbil hippocampus.

Journal: Histology and histopathology
Published: June 16, 2025

Tat-GSTpi suppresses inflammatory responses by regulating ROS/MAPKs/apoptosis signaling pathways.

Tat-GSTpi suppresses inflammatory responses by regulating ROS/MAPKs/apoptosis signaling pathways.

Journal: BMB reports
Published: June 11, 2025

Therapeutic potential of cell-permeable PEP-1-Srxn1 in mitigating oxidative and ischemic damage in the hippocampus.

Therapeutic potential of cell-permeable PEP-1-Srxn1 in mitigating oxidative and ischemic damage in the hippocampus.

Journal: Neurochemistry international
Published: March 05, 2025

Time course analysis of changes in neuronal loss, oxidative stress, and excitotoxicity in gerbil hippocampus following ischemia and reperfusion under hyperthermic conditions.

Time course analysis of changes in neuronal loss, oxidative stress, and excitotoxicity in gerbil hippocampus following ischemia and reperfusion under hyperthermic conditions.

Journal: Histology and histopathology
Published: November 14, 2024

PEP-1-PIN1 Promotes Hippocampal Neuronal Cell Survival by Inhibiting Cellular ROS and MAPK Phosphorylation.

PEP-1-PIN1 Promotes Hippocampal Neuronal Cell Survival by Inhibiting Cellular ROS and MAPK Phosphorylation.

Journal: Biomedicines
Published: September 03, 2024

PFKFB3 ameliorates ischemia-induced neuronal damage by reducing reactive oxygen species and inhibiting nuclear translocation of Cdk5.

PFKFB3 ameliorates ischemia-induced neuronal damage by reducing reactive oxygen species and inhibiting nuclear translocation of Cdk5.

Journal: Scientific reports
Published: June 21, 2024

Neuroprotective Effects of Chaperonin Containing TCP1 Subunit 2 (CCT2) on Motor Neurons Following Oxidative or Ischemic Stress.

Neuroprotective Effects of Chaperonin Containing TCP1 Subunit 2 (CCT2) on Motor Neurons Following Oxidative or Ischemic Stress.

Journal: Neurochemical research
Published: June 20, 2024

TAT-PPA1 protects against oxidative stress-induced loss of dopaminergic neurons.

TAT-PPA1 protects against oxidative stress-induced loss of dopaminergic neurons.

Journal: Molecular and cellular neurosciences
Published: May 01, 2024
Showing 1-12 of 245

Last Updated: 09/26/2026